ARECOR ANNOUNCES AN EXCLUSIVE FORMULATION STUDY COLLABORATION WITH A LEADING GLOBAL MEDICAL PRODUCTS COMPANY TO DEVELOP A STABLE READY TO ADMINISTER PRODUCT
November 01, 2021 07:00 ET | Arecor Therapeutics plc
Arecor Therapeutics plc(“Arecor” or the “Group”) ARECOR ANNOUNCES AN EXCLUSIVE FORMULATION STUDY COLLABORATION WITHA LEADING GLOBAL MEDICAL PRODUCTS COMPANY TO DEVELOP A STABLE READY TO ADMINISTER...
Arecor Announces Positive Headline Results From First Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Candidate for Diabetes
September 20, 2021 08:39 ET | Arecor Therapeutics plc
Arecor Therapeutics plc(“Arecor”, the “Company” or the “Group”) ARECOR ANNOUNCES POSITIVE HEADLINE RESULTS FROM FIRST PHASE I CLINICAL TRIAL OF AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN...
Arecor Logo jpg (002).jpg
Arecor Announces an Exclusive Formulation Study Collaboration With Lilly
May 20, 2021 03:48 ET | Arecor Therapeutics PLC
CAMBRIDGE, United Kingdom, May 20, 2021 (GLOBE NEWSWIRE) -- Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today...
Arecor Logo jpg (002).jpg
Arecor Receives £2.8 Million Grant Award From Innovate UK
March 31, 2021 04:00 ET | Arecor Ltd
CAMBRIDGE, United Kingdom, March 31, 2021 (GLOBE NEWSWIRE) -- Arecor Limited ("Arecor" or "the Company"), the biopharmaceutical company advancing today's therapies to enable healthier lives, today...
Arecor Logo jpg (002).jpg
Arecor's Partner Inhibrx Exercises Its Option to License a New Formulation Developed by Arecor in Accordance With the Terms of Formulation Development Agreement
December 17, 2020 03:00 ET | Arecor Ltd
CAMBRIDGE, United Kingdom, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Arecor Ltd ("Arecor" or "the Company"), the biopharmaceutical company advancing today's therapies to enable healthier lives, today...
Arecor Logo jpg (002).jpg
Arecor Announces Publication of Phase I Data for AT247 in Diabetes Care
December 16, 2020 04:31 ET | Arecor Ltd
CAMBRIDGE, United Kingdom, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Arecor Limited ("Arecor" or "the Company"), the biopharmaceutical company advancing today's therapies to enable healthier lives, today...
Arecor Logo jpg (002).jpg
Arecor Limited: First Patient Dosed in Phase I Clinical Trial of Ultra-Concentrated Rapid Acting Insulin Candidate, AT278, for Diabetes
December 15, 2020 12:38 ET | Arecor Ltd
CAMBRIDGE, United Kingdom, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Arecor Limited ("Arecor" or "the Company"), the biopharmaceutical company advancing today's therapies to enable healthier lives announces...
Arecor Logo jpg (002).jpg
Hikma and Arecor Expand Collaboration
October 20, 2020 03:00 ET | Arecor Ltd
LONDON, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Hikma Pharmaceuticals PLC (Hikma or the Group), the multinational pharmaceutical company, and Arecor Limited, the biopharmaceutical company advancing...
Arecor Logo jpg (002).jpg
Arecor to Present at EASD 2020
September 21, 2020 04:00 ET | Arecor Ltd
CAMBRIDGE, United Kingdom, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Arecor Limited ("Arecor" or "the Company"), the biopharmaceutical company advancing today's therapies to enable healthier lives, today...
Arecor Logo jpg (002).jpg
Arecor announces Phase 1 of AT247 at ADA
June 15, 2020 02:03 ET | Arecor Ltd
ARECOR PRESENTS POSITIVE RESULTS FOR THE FIRST PHASE I CLINICAL TRIAL OF AT247,A NOVEL ULTRA-RAPID ACTING INSULIN AT247 delivers significantly accelerated absorption of insulin compared to best in...